Donald Bergstrom

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RLAY

Current role

Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Relay Therapeutics, Inc. (RLAY)	M.D., Ph.D. President, Research & Development	$543,375	$600,000	$5,212,800	—	$244,519	$12,703	$6,613,397
2023	Relay Therapeutics, Inc. (RLAY)	M.D., Ph.D. President, Research & Development	$525,000	$600,000	$2,931,929	$4,272,790	$236,250	$7,094	$8,573,063
2022	Relay Therapeutics, Inc. (RLAY)	M.D., Ph.D. President, Research & Development	$500,000	—	$1,323,681	$1,748,402	$200,000	$11,255	$3,783,338
2021	Relay Therapeutics, Inc. (RLAY)	M.D., Ph.D. President, Research & Development	$475,000	—	$1,198,716	$1,618,816	$237,500	$9,760	$3,539,792
2020	Relay Therapeutics, Inc. (RLAY)	M.D., Ph.D. President, Research & Development	$440,000	—	—	$435,276	$220,000	$9,816	$1,105,092
2019	Relay Therapeutics, Inc. (RLAY)	President, Research & Development	$406,850	—	—	$330,652	$179,014	—	$916,516

No earnings-call appearances or filed executive changes recorded yet.